Go With the Flow: Does Clinical Equipoise Remain for Deferral of Angiographically Intermediate Left Main Coronary Artery Disease With Hemodynamic Significance?

By sjmartinez • June 21, 2023

Chester RC, Parikh RV. Go With the Flow: Does Clinical Equipoise Remain for Deferral of Angiographically Intermediate Left Main Coronary Artery Disease With Hemodynamic Significance? Circ Cardiovasc Interv. 2023 Jun;16(6):e013113. doi: 10.1161/CIRCINTERVENTIONS.123.013113. Epub 2023 Jun 20. PMID: 37339236.

Tags: angiography, Cardiology/Epi, coronary artery disease, drug-eluting stents, Editorials, percutaneous coronary intervention, Publications

A deep learning phenome wide association study of the electrocardiogram

Hughes JW, Theurer J, Vukadinovic M, Rogers AJ, Somani S, Kang G, Ghazizadeh Z, O'Sullivan JW, Jain SS, Gomes B, Salerno M, Ashley E, Zou[...]

Novel insights into post-myocardial infarction cardiac remodeling through algorithmic detection of cell-type composition shifts

Gural B, Kirkland L, Hockett A, Sandroni P, Zhang J, Rosa-Garrido M, Swift SK, Chapski DJ, Flinn MA, O'Meara CC, Vondriska TM, Patterson M, Jensen[...]

The accumulation of progerin underlies the loss of aortic smooth muscle cells in Hutchinson-Gilford progeria syndrome

Kim PH, Kim JR, Heizer PJ, Jung H, Tu Y, Presnell A, Scheithauer J, Yu RG, Young SG, Fong LG. The accumulation of progerin underlies[...]